Abstract
Knowledge translation (KT) involves implementation of evidence-based strategies and guidelines into practice to improve the process of care and health outcomes for patients. Findings from pragmatic trials may be used in KT to provide patients, healthcare providers and policymakers with information to optimize healthcare decisions based on how a given strategy or intervention performs under the real world conditions. However, pragmatic trials have been criticized for having the following problems: i) high rates of loss to follow-up; ii) nonadherence to study intervention; iii) unblinded treatment and patient self-assessment, which can potentially create bias; iv) being less perfect experiments than efficacy trials; v) sacrificing internal validity to achieve generalizability; and vi) often requiring large sample sizes to detect small treatment effects in heterogeneous populations. In this paper, we discuss whether these criticisms hold merit, or if they are simply driven by confusion about the purpose of pragmatic trials. We use the Cardiovascular Health Awareness Program (CHAP) trial--a community randomized pragmatic trial designed to assess whether offering a highly organized, community-based CHAP intervention compared to usua...Continue Reading
References
Oct 1, 1984·Statistics in Medicine·S YusufR Peto
Apr 29, 2000·Journal of Clinical Epidemiology·K H HumphriesJ J Spinelli
Aug 15, 2002·American Heart Journal·Peter C AustinJack V Tu
Oct 5, 2002·Stroke; a Journal of Cerebral Circulation·David L Tirschwell, W T Longstreth
Mar 7, 2003·Lancet·Christopher J L MurrayDavid B Evans
Nov 25, 2004·Complementary Therapies in Medicine·Hugh Macpherson
Jan 19, 2005·Medical Care·Douglas S LeeJack V Tu
May 3, 2005·American Heart Journal·Eric L EisensteinRobert M Califf
May 21, 2005·BMJ : British Medical Journal·Gunn Elisabeth VistAndrew David Oxman
Mar 29, 2008·Preventive Medicine·Janusz KaczorowskiMegan Carter
May 6, 2008·Lancet·Carlene M M LawesUNKNOWN International Society of Hypertension
Jul 10, 2008·The Canadian Journal of Cardiology·Charlotte JonesLarry W Chambers
Apr 8, 2009·Journal of Clinical Epidemiology·Daniel Schwartz, Joseph Lellouch
Apr 8, 2009·Journal of Community Health·Tina KarwalajtysBrian Hutchison
Jan 8, 2010·BMC Medical Research Methodology·Lehana ThabaneCharles H Goldsmith
Jul 31, 2010·Journal of Clinical Epidemiology·Daniel L RiddleDennis C Ang
Dec 7, 2010·Journal of Clinical Epidemiology·Onil K BhattacharyyaMerrick Zwarenstein
Feb 9, 2011·BMJ : British Medical Journal·Janusz KaczorowskiRolf J Sabaldt
May 6, 2011·The New England Journal of Medicine·James H Ware, Mary Beth Hamel
Jan 23, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ron GoereeBrandon Zagorski
May 22, 2013·Clinical Trials : Journal of the Society for Clinical Trials·David L Sackett
Jun 25, 2013·Clinical Trials : Journal of the Society for Clinical Trials·David L Sackett
Oct 1, 2014·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Natasha FernandesNeera Bhatnagar
Citations
Apr 6, 2016·Implementation Science : IS·Lisa DolovichDavid Price
Oct 22, 2016·Journal of Clinical Epidemiology·Guowei LiUNKNOWN 2016 Symposium on Registry-Based Randomized Controlled Trials in Calgary
Jan 13, 2018·BMC Medicine·Clare H LuymesMattijs E Numans
Apr 3, 2020·BMJ Open·Elizabeth AlvarezShailla Vaidya
Oct 18, 2019·BMJ Open·Elizabeth AlvarezJohn Fortuna
Jun 21, 2019·Open Heart·Ann Hovland-TånnerydHans E Persson
May 5, 2016·Topics in Stroke Rehabilitation·Michal Kafri, Ruth Dickstein
Jul 12, 2017·Pilot and Feasibility Studies·Lehana Thabane, Gillian Lancaster
Jul 2, 2020·Cardiology in the Young·Brett R AndersonUNKNOWN Pediatric Heart Network
Aug 28, 2020·BMC Medical Research Methodology·Robert FahedJean Raymond
Dec 25, 2019·Trials·Gina AgarwalJanusz Kaczorowski
Feb 17, 2021·Trials·Tim E Darsaut, Jean Raymond
Apr 23, 2021·BMC Geriatrics·Magnus NordJan Marcusson